ConductScience.org, home

Library / Trials

Appropriate and Value-based Access to Inpatient Rehabilitation (ARVA)

NCT07933939, Completed, Istituti Clinici Scientifici Maugeri SpA

Trial 8

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleAppropriate and Value-based Access to Inpatient Rehabilitation (ARVA)ClinicalTrials.gov
NCT numberNCT07933939ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
Enrollment2,210 participants, actualClinicalTrials.gov
Lead sponsorIstituti Clinici Scientifici Maugeri SpAClinicalTrials.gov
ConditionsInpatient Rehabilitation, Neurological Rehabilitation, Musculoskeletal RehabilitationClinicalTrials.gov
First posted2026-11-12ClinicalTrials.gov
Last updated2026-11-12ClinicalTrials.gov

Registered outcomes 6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimarySDO-R diagnosis defined by ICD 9 CM codesDay 1 and on the day of discharge (up to 6 months)
Categorical variable number/rate International Classification of Disease (ICD 9 CM) to describe an health status in relation to: ICD 9 CM code for functional diagnosis ICD 9 CM code for etiological diagnosis ICD 9 CM code for a maximum of 2 markers of complexity ICD 9 CM code for a maximum of 2 -morbidities or clinical complications
ClinicalTrials.gov
PrimaryType of Rehabilitation setting as defined by the Italian Ministry of HealthDay 1
Categorical variable number/rate Admission codes describing the type of inpatient rehabiliation admissions: code 56 (complex orthopaedic and neurological ) or code 75 (highly complex acquired brain injury) or code 28 (highly complex spinal cord injury)
ClinicalTrials.gov
PrimaryBarthel Index (BI)Day 1 and on the day of discharge (up to 6 months)
The Barthel Index is a clinical assessment tool used to measure a patient's level of functional independence and mobility in basic Activities of Daily Living Total score 0-100 (0= total dependency; 100= total independency) Numerical variable Expressed as mean (SD)/median (range)
ClinicalTrials.gov
PrimaryRehabilitation Complexity Scale-Extended (RCS-E vers 13)Day 1 and on the day of discharge (up to six months)
RCS-E it is a clinical assessment tool used to measure the complexity of a patient's care and rehabilitation needs RCS scores 0-22 where 0= no rehabilitation need; 22= maximum complexity of rehabilitation needs Numerical variable Expressed as mean (SD)/median (range)
ClinicalTrials.gov
SecondaryNeuro-Rehabilitation Experience Questionnaire (NREQ)Last week of admission
The NREQ evaluates patient experience on 17 items, 3-point Likert scale: "mostly agree", "mostly disagree", and "not sure" An Italian version (NREQ-IT) is created and validated as part of this study Results are expressed as % "mostly agree", "mostly disagree", and "not sure" for each item
ClinicalTrials.gov
SecondaryPatient Categorization Tool (PCAT)Day 1
The Italian version (PCAT-IT) is created and validated as part of this study The scale allows the description of category A (score=3), B (score=2) , C needs (score =1) across 16 domains. An additional score is added for the Anticipated Duration of Stay: Short stay/assessment = 0, Medium stay = 1, Long stay = 2) Total scores= 16 (low level of needs) to 50 (maximum level of needs). Results are expressed as % of A, B, C needs; mean (SD) and median (range) of the total score
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
28077130BACKGROUNDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)